Opportunity dossier O-3096

Recurring need documented in 2 independent public source items.

First seen 2026-08-18 · Last updated 2026-08-30 · Recalculated daily

13.2

Evidence confidence, not a return forecast

Independent source items, deduplicated by post

Public source families

Payment evidence: current spend or explicit intent

ProblemThe source-linked evidence below documents the recurring problem.

People affectedPeople represented in the linked public discussions.

Named alternativesNo existing alternative is named in the qualifying evidence yet.

Weekly mentions · 12 weeks▲ Warming ×2.0

06-0807-0608-0308-24

This dossier's trend factor is 2.0, capped at 2.0.

Representative evidence

1 public excerpts · 2 items in the full chain

Pain★★★☆☆First-hand pain

Post title: Help with reducing screen time

I’ve tried screen time limits and ClearSpace, whic…

The public layer keeps only a minimal excerpt. Open the source for full context.

Reddit2026-08-27View source ↗

What this evidence does not show yet

To reach Corroborated we still need:

1 more independent post(s) — we have 2
the same need restated in another source family, or by 3 different authors

No first-hand payment statement is on record here, so this page carries no pricing suggestion. A price with no payment evidence behind it is a guess wearing a number.

Follow how this opportunity evolves

Every item traceable · free · we email you only when this market actually changes

Watch this market Weekly editor pick (separate list)

Scoring summary

Evidence confidence = strength × evidence volume × source diversity × payment × competition × trend × 10. Counts use independent content items; only first-hand pain, current spend, explicit willingness to pay and concrete feature requests affect the score. Repeated posts by one author are discounted. Scoring and status changes follow deterministic rules.

“Payment-backed” means first-hand payment evidence exists in the record. It does not mean the business is worth building. “Fading” is a recency tag shown alongside any evidence level, not a lower level. Read the full methodology.